Silexion Therapeutics warrants exercised for 3,216,928 shares at $0.2603

Silexion says holders have exercised Series E warrants for 3,216,928 ordinary shares at $0.2603 each, with gross proceeds expected at $837,366.36; closing is set for about Sept. 29, 2026.